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Background: Adherence to nebulizer treatments in adults with cystic fibrosis (CF) is often low. A new complex intervention
to help adults with CF increase their adherence to nebulizer treatments was tested in a pilot randomized controlled trial (RCT)
in 2 UK CF centers. Patients used a nebulizer with electronic monitoring capabilities that transferred data automatically to a
digital platform (CFHealthHub) to monitor adherence over time and to a tailored website to display graphs of adherence data and
educational and problem-solving information about adherence. A trained interventionist helped patients identify ways to increase
their adherence.
Objective: This study aims to explore the mechanisms of action underpinning the intervention.
Methods: A qualitative interview study was conducted concurrently with a pilot RCT. In total, 25 semistructured interviews
were conducted with 3 interventionists at 2 time points, 14 patients in the intervention arm of the trial, and 5 members of the
multidisciplinary teams offering wider care to patients. A framework approach was used for the analysis.
Results: The intervention was informed by a theoretical framework of behavior change. There was evidence of the expected
behavior change mechanisms of action. There was also evidence of additional mechanisms of action associated with effective
telehealth interventions for self-management support: relationships, visibility, and fit. Patients described how building a relationship
with the interventionist through face-to-face visits with someone who cared about them and their progress helped them to consider
ways of increasing adherence to medication. Rather than seeing the visibility of adherence data to clinicians as problematic,
patients found this motivating, particularly if they received praise about progress made. The intervention was tailored to individuals,
but there were challenges in how the intervention fitted into some patients’busy lives when delivered through a desktop computer.
Conclusions: The mechanisms of action associated with effective telehealth interventions for self-management operated within
this new intervention. The intervention was modified to strengthen mechanisms of action based on these findings, for example,
delivery through an app accessed via mobile phones and then tested in an RCT in 19 UK CF centers.
Trial Registration: International Standard Randomized Controlled Trial Number 13076797;
http://www.isrctn.com/ISRCTN13076797
(J Med Internet Res 2020;22(10):e16782) doi: 10.2196/16782
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Introduction
Background
Adherence to medication for chronic conditions is a complex
issue that is sometimes addressed by digital, web-based, mobile,
and telehealth interventions [1-3]. We developed a new
intervention involving a web-based adherence monitoring
system with health professional support to help adults with
cystic fibrosis (CF) increase their adherence to nebulizer
treatments. Although not promoted as telehealth, the intervention
has key components of web-based monitoring and web-based
behavior change materials for use with the chronic condition
of CF. CF is a genetic life-limiting condition affecting
approximately 100,000 people worldwide [4] in which mucus
builds up in the lungs, digestive system, and other organs,
leading to difficulty in breathing, respiratory infections, and
ultimately death. Patients with CF need to take preventative
treatments such as antibiotics and mucolytics through nebulizers
and airway clearance, often alongside many other treatments
creating a complex, onerous treatment regime [5,6]. Adherence
to nebulizer treatments is often low, with objectively measured
adherence found to average 36% compared with 80% estimated
by patients [7]. Low adherence to nebulizer treatments has been
linked to worse health outcomes, including decreased lung
function, increased pulmonary exacerbations requiring treatment
with intravenous antibiotics, and higher service costs [8-11].
We tested the intervention in a feasibility study that included a
pilot randomized controlled trial (RCT) and a mixed methods
process evaluation. We found that a full-scale RCT was feasible
with numbers of pulmonary exacerbations as the primary
outcome. The pilot RCT identified that mean changes to
adherence, a key secondary outcome, were 10% higher in the
intervention arm (95% CI −5.2 to 25.2) [12]. The mixed methods
process evaluation found that the intervention was feasible and
acceptable to patients, interventionists, and health care
professionals in the multidisciplinary teams (MDTs) offering
wider care to patients with CF. As part of the process evaluation,
we conducted qualitative interviews with patients and
interventionists. One of the aims of this qualitative research was
to consider the proposed mechanisms of action underpinning
the intervention in practice. The mechanisms of action explain
how the intervention components might work to produce an
outcome [13,14] and how any theoretical model might be
working within the intervention. Qualitative research can be
undertaken during the development and feasibility phases of
developing complex interventions [14,15] to help researchers
understand how a complex intervention with multiple and
interacting components might work [16]. Qualitative research
within process evaluations can help researchers understand
mechanisms of action by looking for unanticipated and complex
causal pathways through the intervention or unanticipated
consequences of the intervention [17,18], which is useful in
refining the intervention before a full-scale evaluation.
Description of the Intervention
The intervention is complex, with a number of interacting
components [16]. A study by Arden et al (unpublished data,
2020) provides more details on the intervention and development
processes. In summary, an eTrack nebulizer (PARI, Pharma
GmbH) with electronic monitoring capabilities sends
timestamped inhalation data to a 2net Hub (Qualcomm). This
enables real-time monitoring of adherence via securely stored
data on CFHealthHub servers. Adherence data are displayed on
the CFHealthHub website and are visible to patients and health
professionals delivering the intervention. The intervention also
comprises a manualized behavior change component that is
designed to help patients increase their adherence. This is
underpinned by a theoretical model of behavior change (Figure
1) based on the idea that reflective motivation, in which people
rationally weigh up the perceived necessity of a behavior against
the perceived concerns they have about treatment, underpins
adherence behavior. Therefore, some participants would need
to address motivation before other strategies, such as action
planning, could be successfully used. The model of behavior
change is part of a larger logic model [12], informed by
qualitative interviews with adults with CF about their adherence
behavior [19,20] mapped to the Theoretical Domains Framework
[21] and behavior change wheel [22] and developed using a
person-based approach [23]. The behavior change intervention
is delivered by trained health professionals (interventionists) in
a series of face-to-face and telephone meetings with patients.
Interventionists help patients to increase their adherence to
nebulizer treatments by choosing components of the behavior
change intervention to address an individual’s unique issues
identified through baseline questionnaires and discussions during
intervention visits and placed into a toolkit area of the
CFHealthHub website. The interventionists in the pilot RCT
were clinicians employed to deliver the intervention. The
number and location of intervention visits are tailored to
patients’ needs.
Figure 1 [24] shows how the model splits the behavior change
components into components for all participants (including
those with low motivation) and for those with adequate
motivation (#1 to #7) and how those components link to
mechanisms of action (#8 to #13) that lead to increased
adherence. Table 1 describes the different components and the
proposed mechanisms of action in more detail and how they
are delivered within the intervention. The numbers in brackets
in the table are linked to the numbers in Figure 1.
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Figure 1. Theoretical model of behavior change to increase adherence in adults with cystic fibrosis. The Confusion, Hubbub, and Order Scale is a
6-item measure of life chaos. CHAOS: Confusion, Hubbub, and Order Scale.
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Table 1. Components of the intervention and proposed mechanisms of action.




Patients self-monitor their adherence by reviewing
graphs of adherence data by month, week, or time
of the day in CFHealthHub. A simple traffic light
system quickly indicates if patients have hit their
agreed target for treatments (green), have done
some treatments but not hit their target (amber), or
have completed no treatments (red). This enables
patients to understand their adherence patterns
leading to awareness of adherence and increased
motivation to adhere (#8)
Self-monitoring adherence (#1) • Graphs showing red, amber, and green charts of adher-
ence data on CFHealthHub and tables showing the
number of treatments completed compared with pre-
scription data
Interventionist identifies issues with understanding
treatments and unhelpful beliefs about different
aspects of treatment. Patients can see the need to
undergo treatment (increased necessities) and re-
duce any concerns they have about treatments (#9)
Tailored education about treat-
ment (#2)
• Baseline questionnaires and discussions with patients
used by interventionists to identify issues before visits
• Education section on CFHealthHub with information
about CFb and videos about how treatments work and
links to other websites. Interventionists use question-
naires and discussions to identify where patients lack
knowledge or have misconceptions
Other patients with CF talking about how they
overcame different barriers to give patients informa-
tion from peers or someone like them. This allows
patients to see how they can find solutions to
problems (increased self-efficacy) and that it is
possible to change (increased motivation; #10)
Tailored patient stories (videos;
#3)
• Section of CFHealthHub includes talking heads videos
that address adherence barriers. Interventionists use
these with patients if they address an issue that patients
experience
For patients with sufficient motivation
Interventionist works with patient to set goals for
adherence against prescription and life goals that
may help adherence behavior. This allows patients
to work toward a target (increased self-efficacy)
and see how adherence is linked to their life goals
(increased motivation to adhere; #11)
Personalized goal setting (#4) • Graphs in CFHealthHub measure actual adherence
against personalized adherence goals and can be
tracked by interventionists
• Interventionists work with patients during visits to set
personalized adherence and life goals if appropriate
A review of progress toward goals with the patient
helps to increase self-efficacy. Optional notifica-
tions of achievements against progress help patients
to increase motivation to adhere (#11)
Goal review, rewards (#5) • Goals are reviewed during discussions between pa-
tients and interventionists and barriers are identified
• Patients receive messages on mobile phones or in
CFHealthHub to provide motivation to keep going
with behavior changes
Patients create personalized action plans around
daily routines to build adherence that increases
habits and reduces chaos (#12)
Personalized action plans (#6) • Action plans are made by patients with help from in-
terventionists. Action plans are written in a section in
CFHealthHub for patients to refer to
Solutions to common problems with adherence, for
example, what to do when you go on holiday. These
allow patients to solve problems, reducing barriers
to adherence (#13)
Tailored problem solving (#7) • Questionnaires and discussions between intervention-
ists and patients identify practical barriers that make
adherence difficult. These are stored on a problem-
solving section on CFHealthHub
aProposed mechanisms of action are shown in italics.
bCF: cystic fibrosis.
Whilst considering the proposed mechanisms of action in Table
1 in a qualitative study, we identified 3 mechanisms of action
(relationships, visibility, and fit) that Vassilev et al [25] found
in a realist review of effective telehealth interventions that
explain how telehealth supports self-management of long-term
conditions. First, effective telehealth interventions should
consider how relationships with health professionals and peers
are enabled or inhibited. Second, the intervention should enable
the visibility of symptoms to the self and others and provide
feedback to increase knowledge, motivation, and empower
patients, thus enabling reinforcement of behavior change.
Finally, successful interventions should fit, or at least not disrupt,
the everyday lives and routines of patients, including their
existing skills and knowledge. The study by Vassilev et al [25]
is transferable to this intervention because there are key
components of telehealth, namely, the intervention has
web-based monitoring and web-based behavior change
materials, the intervention is concerned with self-management
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(adherence to nebulizer treatments), and the condition being
studied, CF, is a long-term condition. Although relationships,
fit, and visibility are implicit in the stated intervention
components, the ways in which they might work in the
intervention as potential mechanisms of action were not fully
articulated; thus, their importance to the potential effectiveness
of the intervention needed further exploration. In this study, we
explore the mechanisms of action operating in the intervention
by confirming how the expected mechanisms of action identified
in Table 1 worked in the intervention and by showing how
important the mechanisms of action (relationships, visibility,
and fit) identified in the review by Vassilev et al [25] of
telehealth for self-management support were to facilitate the
potential effectiveness of this intervention.
Methods
Study Design
We undertook a feasibility study in preparation for a full-sized
RCT. The study consisted of a mixed methods process
evaluation undertaken concurrently with a pilot RCT in 2 UK
CF centers. In total, 33 adults with CF received the intervention
for 5 months [12]. The process evaluation addressed the
feasibility and acceptability of the intervention and the RCT
and the mechanisms of action of the intervention. The qualitative
component of the process evaluation allowed exploration of the
mechanisms of action at play, and this is the focus of this paper.
The study received ethical approval from the London Brent
Research Ethics Committee (16/LO/0356).
Participants
We conducted 25 semistructured face-to-face interviews, with
patients in the intervention arm of the RCT (n=14),
interventionists (n=3 at 2 time points), and members of the wider
MDT offering care to patients with CF (n=5). We interviewed
more patients in RCT site 1 (n=8) than in RCT site 2 (n=6),
because fewer patients agreed to be interviewed at site 2.
Sociodemographic data for patient participants are shown in
Table 2.






















aIMD: Index of Multiple Deprivation by Postcode [26].
bThe Index measures relative deprivation by UK postal code stratifying into 5 quintiles, where 1 is the most affluent and 5 is the most deprived. By
entering a postal code, it is possible to obtain an indication of the deprivation level where an individual lives.
cThe percentage values for deprivation and baseline objective adherence add up to 99% due to rounding issues.
dMean unadjusted objective adherence over the previous 6 months measured from chipped i-neb nebulizers: high (≥80.0%), moderate (50.1%-79.9%),
low (25.1%-50.0%), and very low (≤25.0%) [11,27].
J Med Internet Res 2020 | vol. 22 | iss. 10 | e16782 | p. 5https://www.jmir.org/2020/10/e16782
(page number not for citation purposes)
Drabble et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
We interviewed all 3 interventionists. They had different
backgrounds: 2 had worked as physiotherapists within the
multidisciplinary health care team who provided care to patients
with CF in that center and one was a psychologist who had not
previously worked in a CF setting. The MDT members were
from a mix of disciplines, including respiratory consultants and
physiotherapists.
Recruitment
During consent for the pilot RCT, 28 of the 33 intervention
patients consented to be approached for an interview. We invited
participants by letter or email and followed up by telephone or
email. Of the 28 available patients, 16 consented to interview,
2 declined, 1 withdrew from the full study, 1 died during the
study, we were unable to contact 7 patients, and we did not
approach 1 patient because of time constraints. Of the 16
consented, 14 were interviewed and 2 patients canceled their
interviews. The 3 interventionists consented to be interviewed
twice during the study, toward the beginning and the end of the
pilot RCT. MDT participants were recruited through the
interventionists at each site. We obtained informed written
consent from all participants before the interview.
Data Collection
Interviews were conducted by SD, AS, and SK. Patients were
interviewed face-to-face in their homes or the hospital depending
on preference, whereas interventionists and MDT interviews
were conducted at the hospital, except one that was by
telephone. We used topic guides as the basis for the interviews,
with questions about the acceptability of different aspects of
the intervention and RCT, and explored which aspects of the
intervention participants perceived to be important in increasing
adherence to nebulizer treatments (mechanisms of action).
Interviews were also open enough to allow patients to describe
their approaches to adherence and any challenges they faced.
The interviews lasted between 11 and 102 min, averaging 56
min. Interviews were digitally audio-recorded and transcribed
verbatim. We removed identifying data before analysis and gave
participants an identification number to maintain anonymity.
Data Analysis
SD and AS conducted the initial coding. We initially derived a
coding framework [28] based on the Theoretical Domains
Framework categories related to adherence [19] and the key
aspects of process evaluation (context, mechanisms, and
implementation) [17]. After initial familiarization with the data,
SD added the telehealth mechanisms of action by Vassilev to
the coding framework, because they were evident in the data
[25]. SD and AS read the transcripts and coded them against
the framework using NVivo software, allowing for other themes
to be identified in the data set that did not fit the framework.
After the initial coding, SD worked with MA to discuss the
relationship between the telehealth mechanisms by Vassilev
(relationships, visibility, and fit) and the expected mechanisms
of action based on behavior change theory. Trustworthiness was
addressed through: researchers writing reflections after each
interview, discussion of the interviews between SD, AS, and
SK during data collection, discussion of the findings between
SD and AC to develop the analysis, and presentations to the
wider research team. We present quotes from patients in the
intervention (P), interventionists (INT), and members of the
MDT to provide examples of the points we are making.
Results
In the qualitative interviews, we found evidence of the expected
behavior change mechanisms of action. The mechanisms of
action that appeared to work during the pilot RCT are presented
in Table 3.
In a study of the mechanisms of action in telehealth interventions
for self-management support, Vassilev et al [25] emphasized
the importance of some mechanisms of action (relationships,
visibility, and fit). These mechanisms are implicit in some of
the behavior change mechanisms of action discussed earlier,
but Vassilev’s work identified how important they were in
facilitating the potential effectiveness of this intervention. These
are discussed below.
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Table 3. Description of how behavior change components and mechanisms of action worked in the intervention.
Examples of quoteEvidenceComponent and mechanism
of action
Self-monitoring (#1) leading to acute awareness of adherence and increased motivation to adhere (#8)
• “I’m very much more conscientious of how much I’m
doing it and almost kind of realized the importance
• Patients found it motivating to see the green bars on
their graphs because it was a quick and easy way to
of doing it a lot more.” (P1, site 2)see their progress
• “They kind of say in theory it’s a good idea and they
like it but somehow they’re not doing it.” (INT2, site
• Some patients reported self-monitoring leading to in-
creased awareness of adherence level although this
2)did not always lead to increased motivation to adhere
to treatment or change to adherence behavior
Tailored education about treatment (#2) leading to increased necessities and decreased concerns about doing treatments (#9)
• “People have said that its nice having something that
you know has been prepared by […] professionals so
• Educational components such as the treatment videos
were perceived by clinicians and patients as beneficial
you know the information is accurate without it beingand a trusted information source
scary.” (INT1, site 2)
• “I don’t know what it is but if someone tells me to do
something, yes I take it on board but I’m not very
• Some patients found it difficult to translate the educa-
tion into action. The pages were not accessed frequent-
good at putting that into action.” (P2, site 1)ly outside meetings with interventionists
Tailored patient stories (videos; #3) leading to increased self-efficacy and motivation to adhere (#10)
• “I don’t need to listen to somebody feeling sorry for
themselves.” (P5, site 1)
• The talking heads videos did not appear to increase
self-efficacy and motivation (#30) for most patients
in the sample because they feared comparison with
others with CF
• “Some of them said about the videos of people ‘I've
not looked because I don't want to see and compare
• Interventionists sometimes did not share the videos
because they found it difficult to know the content of
myself to that person’” (INT1, site 1)each video in detail and were concerned about sharing
videos that could upset patients
Personalized goal setting (#4) leading to increased self-efficacy and motivation to adhere (#11)
• “Again, the graphs and stats and things like that […]
motivate you, keep you in the right place.” (P4, site
• Some participants found it motivating to set targets
that they could work to achieve
2)
• “They know they are clearly struggling to do what's
required so some people were quite happy to be told
• Some patients preferred to set lower, achievable goals
they could do less [than 100%].” (INT2, site 2)
• “The one I did this morning, we put her at 100% and
I said that’s quite high and she was like, no, her words
• Some low adherers wanted to set unrealistically high
goals that were unachievable
were like, all or nothing.” (INT1, site 2)
• “I do manage [treatments] practically twice a day so
[the interventionist] didn’t really set me any goals.”
• Some high adherers did not set goals
(P1, site 2)
Goal review, rewards (#5) leading to increased self-efficacy and motivation to adhere (#11)
• “I want to receive reminders—target achieved.” (P3,
site 2)
• Notifications were unavailable during the pilot, but
some patients thought they would help them adhere
Personalized action plans (#6) leading to increased habits and reduced chaos (#12)
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Examples of quoteEvidenceComponent and mechanism
of action
• “It [has] helped because now I’m starting to think of
things that I can link with […] it’s making me make
a conscious effort toward helping my health.” (P2,
site 2)
• “My life is up and down you know and saying for
every 5 days a week for example I’m going to do this
at this time it don’t work for me at all.” (P2, site 1)
• Interventionists and some patients described how ac-
tion plans were beneficial for a minority of patients
to create a habit or routine, but some patients disliked
them because they did not want to form habits
• “[A patient] said to be honest I did feel like you know,
I’m not a child, that was her reaction but she was quite
nice about it” (INT 2, site 2)
• Patients and interventionists perceived that the action
plans could sometimes feel simplistic
Tailored problem solving (#7) leading to reduced barriers to adherence (#13)
• “If you’re getting in a mess with the equipment, bits
and bobs like that—the few things that I investigated
on that were really quite helpful.” (P4, site 2)
• Most patients interviewed did not access the problem-
solving part of the website outside the meetings with
interventionists but found the resources useful if they
did encounter a problem
Relationships: Building a Relationship With the
Interventionist
A trained interventionist delivered the intervention through a
series of tailored meetings where patients and interventionists
discussed all aspects of adherence behavior. The way the
interventionists communicated was intended to encourage open
and honest communication about adherence, from which a
realistic understanding of the barriers that patients faced in their
daily lives could emerge. The importance of the style of
communication was addressed in the intervention manual and
during the interventionists’ training program. In the pilot RCT,
patients and interventionists emphasized the importance of these
interactions between interventionists and patients in helping
them to improve their adherence. In particular, they valued
where the interactions occurred and how interventionists
communicated with patients.
Meetings in a patient’s home were face-to-face, lasting up to
an hour. These meetings were highly valued by some patients
because patients perceived that the time given and effort made
to travel to a patient’s home by the interventionist were
indications of their interest in the patient’s adherence:
I feel like there’s a lot more care in that they’re more
interested in the patient. [P8, site 1]
The fact that visits were home-based was also important to some
patients because this venue provided a safer space in which
patients had time to talk in-depth about adherence.
Interventionists also appreciated being able to find out about
the lives of patients and some of the barriers they faced by
seeing their living conditions. For some patients, this was an
important first step in reflecting on their adherence behavior
and trying to understand and identify potential barriers. It also
demonstrated to patients the importance of focusing on their
adherence:
Physically coming to your home to talk to you about
it, makes you think right, okay [...] I’m focused here.”
[P3, site 1]
Face-to-face meetings also gave the opportunity for informal
talk, which helped to establish a rapport between patients and
interventionists. One interventionist felt that the script-like
nature of the intervention could prevent relationship building,
so they tried to make the intervention visits flow by including
general chit-chat and letting patients make conversation at their
own pace. This contributed to patients feeling like the
interventionists displayed a caring attitude toward them:
She’s really nice and I think she’s very caring, for me
to see her face-to-face has helped. [P8, site 1]
This caring attitude was an important aspect in building a
relationship that had the potential to help the patients increase
their adherence by allowing them to be open about the barriers
they faced to adherence.
Visibility: Self and Others Monitoring Adherence
Visibility was a key aspect of the intervention. Self-monitoring
of real-time adherence data in the form of graphs and tables
against personalized goals, in combination with open discussions
about adherence behavior (see Relationships: Building a
Relationship With the Interventionist), was intended to raise the
visibility of adherence for patients and clinicians by aiding
memory about specific instances of adherence or nonadherence.
Discussions could then focus on identifying barriers to
adherence, which could be addressed to improve self-efficacy.
On the other hand, although monitoring of data by the
multidisciplinary health care team was part of the intervention,
it was not planned as a central component of the intervention
and was not linked to a mechanism of action to increase
adherence directly. In the pilot RCT, it was apparent that
visibility to the self was an important motivator to improve
adherence while visibility to others, that is, people they felt
accountable to, could also be a motivator.
In the pilot RCT, we found that visibility to the self-operated
as expected through self-monitoring (Table 3). Visibility to
others operated when the intervention allowed the
interventionist, and with patient consent, their multidisciplinary
health care team, to see adherence data. Although most patients
we interviewed chose to share their data with their health care
J Med Internet Res 2020 | vol. 22 | iss. 10 | e16782 | p. 8https://www.jmir.org/2020/10/e16782
(page number not for citation purposes)
Drabble et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
team, some patients did not always like being monitored by
others. Indeed, some members of the multidisciplinary health
care team worried that the intervention could be perceived as
unwelcome, described as Big-Brotherish by one interviewee
(MDT1, site 2), involving the health care team checking up on
patients or telling them off.
Patients who chose to share their data described how others
monitoring adherence could make them accountable to someone
else in their health care team. They also described how others’
monitoring motivated them to adhere through a desire to look
good in front of others:
If I go to click and I know that I haven’t done it, I
know that my doctor knows that I haven’t done it. So
I suppose in a weird way that’s kind of how I’m
motivated. [P4, site 1]
Offering praise to patients to increase their adherence could
further motivate patients. For example, although this was not
specified as part of the intervention, one of the interventionists
would text patients with praise or encouragement to keep going
if graphs showed improvements:
I just periodically look at the tables to see how they’re
doing and then I text them a response of what I’ve
seen and that’s been quite nice you know, they’ve sort
of liked that, I’ll say “oh I’ve just checked and you’re
doing really well” you know “keep it up” sort of
thing. [INT1, site 2)]
Patient 3 (site 2): I like knowing that I’m being, not
monitored and stuff, but because of when that text
from [the interventionist] she was like “you’re doing
absolutely amazing,” and because it is hard and […]
bringing in the reality of illness every day and then
saying “oh you’re doing amazing.”
Interviewer: Mm so that extra support as well that
someone is keeping an eye out
Patient 3: Yeah, that you’re not alone.
Fit: A Better Fit for Others?
The intervention was developed to be tailored to individual
patients so that the education about treatments, setting goals
and action plans, and problem solving fitted patients’ specific
needs. Particular content identified by the interventionists could
be added to the toolkit area of the website, offering a tailored
space for each patient. In addition, the intervention was tailored
to patient circumstances by offering options for interventionist
visits in the patient’s home, hospital, or by telephone.
In the pilot RCT, patients valued this tailoring and believed that
it facilitated adherence improvement because not every patient
had the same experience or background, so it was important
that the intervention allowed patients to focus on the aspects
that were most useful to them:
I think there are different age groups, there’s different
educational backgrounds, it’s different people with
different levels of intelligence. So you have to kind of
throw it in there that covers all those people and then
they opt in and out of what suits them best. [P3, site
1]
Although patients appreciated the ability to tailor the
intervention, it was important to them that this tailoring was
patient-led, that is, tailored to the patient’s needs rather than the
interventionist suggesting or even dictating what targets and
goals should be set by the patient:
Sometimes going with what the patient feels, y’know
if you think it might be a good idea for them to have
an action plan or a coping plan and some of them
just don’t really want to do that, even though you
think it might be valuable for them. [INT1, site 2]
One patient with high baseline adherence appreciated how the
interventionist recognized that they did not need to set a goal
to improve adherence, that is, they did not believe they needed
some aspects of the intervention:
She said there wasn’t really a point because I was
already so good at doing them. [P1, site 2]
However, there were problems around fit with patients’
perceived needs and lives, with some of the patients seeing the
intervention as a better fit for others rather than themselves.
Although most patients in the sample believed the intervention
was useful, some patients with baseline high adherence did not
see the need for setting action plans, but believed that those
struggling with adherence would benefit from these. Some
patients also perceived that education, problem solving, and
video components were more useful for other people, such as
younger or newly diagnosed patients with less knowledge:
Well it would be for, I think for younger people but
obviously I know what CF is, I know the ins and outs
of it. [P1, site 2]
Importantly, some patients believed that the intervention did
not fit their lifestyles because they were busy and could not
access the intervention away from their desktop. For example,
although the toolkit area was appreciated by patients,
interventionists noticed that they were unlikely to look at the
materials outside the meetings. Patients described not having
time to log into the website and preferring an app to access the
website flexibly when away from home. There was also an issue
around fit with priorities in life. For one patient, adherence was
low down their list of priorities compared with work, although
there were signs that the intervention had started to help them
challenge that belief:
Work is a helluva lot more important and I don’t see
my health as important as it should be, so my
treatments are probably quite low on my ranking of
things [...], but obviously I need to start changing
that because it’s not turning out well. [P2, site 2]
There was a view among health professionals that the
intervention fitted the needs and priorities of patients with
moderate baseline adherence rates because high adherers were
adhering without the intervention, and low adherers, who
perhaps had the most need, were difficult to engage:
The girl who is the worst adherer out of all those
who’s got the chaotic life was the one who thought
there was absolutely no need to do any plans. But I
think it’s almost like her lifestyle is that chaotic that
its quite difficult to make a plan. She really didn’t see
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In this study, we described how components and mechanisms
of action for behavior change planned within a new intervention
potentially helped patients to increase adherence to nebulizer
treatments. We also described how mechanisms of action for
effective telehealth interventions for self-management support
(relationships, visibility, and fit) [25] were operationalized and
valued by patients using the intervention. Patients described
how building a relationship with the interventionist through
face-to-face visits in the home with someone who cared about
them and their progress helped them to consider ways of
increasing adherence to medication. Rather than seeing the
visibility of adherence data to clinicians as problematic, patients
found this motivating because it made them accountable to
someone else, particularly if they received praise about progress
made. Although the intervention was tailored to individuals,
there were challenges in how the intervention fitted into some
patients’ busy lives, particularly when delivered through a
desktop computer. The intervention was perceived as a better
fit for other patients, for example, those who were younger or
less knowledgeable. Interventionists identified a middle group
of patients with moderate baseline adherence who might benefit
more from the intervention.
Comparison With the Literature
Sitting down face-to-face with an interventionist provided
participants with someone who they felt cared about them,
providing motivation to increase their adherence. This echoes
previous research that has shown how the human aspect of a
telehealth intervention helped to build rapport and trust that
could help a patient to change their behavior [29]. Although
other research has found that self-management may be facilitated
by clinic visits [30], in this study, interventionists and patients
preferred home visits because they showed that the
interventionist was invested in their care, put them at ease, and
allowed them to focus on adherence.
The intervention worked through making adherence visible to
patients, thereby empowering them to change behaviors. In
terms of visibility to others, our study supported research that
health care practitioners can be more concerned about negative
aspects of surveillance than patients [25], although there was
some evidence that those wishing to keep adherence private
opted out or withdrew from the pilot RCT. Mohr et al [31]
coined the term supportive accountability to describe how a
trustworthy individual with expertise can support engagement
with digital interventions [32]. In our study, this supportive
accountability went beyond facilitating engagement and
appeared to facilitate outcomes directly. Patients in our study
appreciated praise from clinicians when they improved their
adherence. Praise is a part of rewards that can facilitate
adherence [19,30] by building motivation and self-efficacy [33]
and by providing a supportive environment for behavior change
[34]. Research has suggested that rewards may work best in
combination with identifying barriers and problem solving [35],
which both occurred in this intervention.
Vassilev et al [25] suggested that a fit to everyday needs, skills,
and daily life was important for intervention success. Research
suggests that the fit may help to increase autonomy and thus
motivation to change behavior [32]. Our finding that the
intervention sometimes did not fit into people’s busy lives is
supported by research exploring barriers to adherence in CF
where people often cite being too busy to adhere to treatments
[19,36-45] and social and work demands creating competing
priorities [19,36,46]. This highlights the importance of offering
the intervention on an app to enable patients to access adherence
data away from their desktop. Some patients also perceived that
the educational aspects of the intervention fit better with the
needs of younger or newly diagnosed patients who had less
knowledge of nebulizer treatments. Research with adolescents
and young adults has suggested that they may face similar
barriers to adherence as adults [36,38-40,42]. Although the
educational aspects of the intervention, such as the videos of
how treatments work, may have the potential for use with that
group or for those who receive a later diagnosis, we would argue
that education alone is unlikely to be sufficient to increase
adherence.
We also found perceptions that the intervention fits some groups
better than others based on their adherence level with a group
of moderate adherers seeming to benefit and engage more than
low or high adherers. This could support research into grouping
patients by adherence level [11,27], which may have
implications for health outcomes [11].
Strengths and Limitations
This study had some limitations. The sample of patient
participants at one of the sites was small because fewer patients
agreed to be approached for interview when they were recruited
for the pilot RCT. Despite this, we have provided an
understanding of patients’ experiences of a new intervention
and how the mechanisms of action operated in practice.
Implications
We modified the intervention based on the results of the wider
process evaluation, including the insights raised here [12]. Key
implications for the intervention were that the interventionist
was a very important aspect of the intervention; there needed
to be a feedback mechanism to reward patients for meeting their
targets in order to maintain motivation, and that the intervention
needed to fit into busy lives, highlighting the need for an app
that was produced for use in a future full-scale RCT.
Conclusions
This behavior change intervention with telehealth components
had the expected behavior change mechanisms of action and
mechanisms of action associated with effective telehealth
interventions for self-management support. The intervention
was modified to strengthen mechanisms of action based on these
findings, for example, delivery through an app accessed via
mobile phones, which is ready for testing in an RCT in 19 UK
CF centers.
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